Tacrolimus FDA approval date

The FDA approved Tacrolimus on 8 Apr 1994.

FDA approval date
8 Apr 1994

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant RecipientsNCT06126380Eledon PharmaceuticalsPhase 2Enrolling by invitation2029-12Estimated
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770Eledon PharmaceuticalsPhase 2Completed2025-09-11Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1994-04-08DayTacrolimusFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA050708", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["PROGRAF"], "active_ingredients": ["TACROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19940408", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026